- Home
- PNW vs SRPT Comparison
PNW vs SRPT Comparison
Compare PNW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNW
- SRPT
- Stock Information
- Founded
- PNW 1985
- SRPT 1980
- Country
- PNW United States
- SRPT United States
- Employees
- PNW N/A
- SRPT N/A
- Industry
- PNW Electric Utilities: Central
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- PNW Utilities
- SRPT Health Care
- Exchange
- PNW Nasdaq
- SRPT Nasdaq
- Market Cap
- PNW 10.3B
- SRPT 9.8B
- IPO Year
- PNW N/A
- SRPT 1997
- Fundamental
- Price
- PNW $94.45
- SRPT $53.79
- Analyst Decision
- PNW Buy
- SRPT Buy
- Analyst Count
- PNW 10
- SRPT 22
- Target Price
- PNW $93.75
- SRPT $156.77
- AVG Volume (30 Days)
- PNW 1.4M
- SRPT 2.8M
- Earning Date
- PNW 05-01-2025
- SRPT 04-30-2025
- Dividend Yield
- PNW 3.80%
- SRPT N/A
- EPS Growth
- PNW 18.82
- SRPT N/A
- EPS
- PNW 5.24
- SRPT 2.34
- Revenue
- PNW $5,124,915,000.00
- SRPT $1,901,979,000.00
- Revenue This Year
- PNW $1.41
- SRPT $66.51
- Revenue Next Year
- PNW $5.85
- SRPT $21.66
- P/E Ratio
- PNW $18.02
- SRPT $23.00
- Revenue Growth
- PNW 9.13
- SRPT 52.97
- 52 Week Low
- PNW $70.72
- SRPT $48.01
- 52 Week High
- PNW $96.50
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- PNW 57.07
- SRPT 31.45
- Support Level
- PNW $93.09
- SRPT $53.02
- Resistance Level
- PNW $95.00
- SRPT $56.34
- Average True Range (ATR)
- PNW 2.68
- SRPT 4.23
- MACD
- PNW 0.10
- SRPT 1.05
- Stochastic Oscillator
- PNW 79.40
- SRPT 29.70
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in the largest nuclear plant in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.